Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$16.20 USD
-0.03 (-0.18%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $16.20 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Avadel Pharmaceuticals PLC. has a market cap of $1.58B, which represents its share price of $16.23 multiplied by its outstanding shares number of 97.10M. As a small-cap company, AVDL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AVDL 16.20 -0.03(-0.18%)
Will AVDL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVDL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVDL
Is Actinium Pharmaceuticals (ATNM) Stock Outpacing Its Medical Peers This Year?
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
AVDL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Avadel (AVDL) Have the Potential to Rally 27.95% as Wall Street Analysts Expect?
Acadia & ECU Health Expand Behavioral Care Access in North Carolina
Corcept Shares Rise 39.6% in YTD: How Should You Play the Stock?
Other News for AVDL
Doji - Bearish? appears for AVDL after 0.18% move
Stochastic Reached Overbought appears for AVDL after 3.64% move
Craig-Hallum Sticks to Their Buy Rating for Avadel Pharmaceuticals (AVDL)
Is AVDL preparing for a move? Bollinger Band Squeeze shows up after gaining 1.62%
Wells Fargo Reaffirms Their Hold Rating on Avadel Pharmaceuticals (AVDL)